US › Healthcare

Painreform Ltd (PRFX)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$1.02+0.99%

Last close · 2026-09-17

Latest quarter · ended 2025-12-31

Revenue

$17,000

Net profit

$-4.8M

EPS

$0.00

EPS estimate

$0.00

Net margin

-28,458.8%

Key statistics

Market cap

$3.0M

Forward P/E

0.0

P/B

0.20

Book value

$10.29

EPS (TTM)

$-3.86

52-week high

$7.95

52-week low

$0.85

50-day MA

$1.10

200-day MA

$2.45

Beta

1.04

Analyst view

Analysts rate Painreform Ltd a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $12.00.

Shareholding

Institutions

6.69%

Largest institutional holders

Fund	Stake
Yorkville Advisors Global, LP	2.67%
Citadel Advisors Llc	0.43%
Morgan Stanley - Brokerage Accounts	0.05%
UBS Group AG	0.03%
Advisor Group Holdings, Inc.	0.00%
SBI Securities Co Ltd	0.00%
XTX Topco Ltd	0.00%
TWO SIGMA SECURITIES, LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Painreform Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.